Udayavni Special
  • Home
  • Bharat Biotech

Bharat Biotech to pay compensation if Covaxin causes side effects

Experts’ group slam critics of India’s COVID-19 vaccines approval process

Two districts of K’taka receive over two lakh doses of Covishield

Covaxin shipped to 11 cities in India, says Bharat Biotech

1st consignment of Covishield vaccines leaves Serum Institute

Volunteer’s death in Bhopal not related to our vaccine: Bharat Biotech

Bharat Biotech to begin phase-1 trials of its intranasal vaccine for COVID-19 in Feb-March

First supply of Covid-19 vaccine likely to be sent shortly: Centre to states, UTs

Bharat Biotech, Serum Institute pledge for smooth rollout of COVID-19 vaccines

Bharat Biotech achieved a milestone in indigenous vaccinology: Min Sudhakar

3 more test positive for COVID-19 UK strain in K’taka: Min Sudhakar

COVID-19 vaccine to cost $3-4 to govt, $6-8 in pvt mkt says Serum Institute

India approves Oxford’s, Bharat Biotech’s COVID-19 vaccines for restricted emergency use

Bharat Biotech recruits 23k volunteers for COVID-19 vaccine trials

Bharat Biotech on course to have 26,000 volunteers for Phase-3 clinical trials of Covaxin

Covaxin can work against mutated Covid-19 virus, says Bharat Biotech Chairman

Bharat Biotech, Ocugen to co-develop Covaxin for US market

Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin

How is govt preparing for COVID-19 vaccination in the country?

Free COVID-19 vaccine for all in Kerala: CM Vijayan

Country’s first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT

Will take COVID-19 vaccine; safety, efficacy not a concern: Kiran Mazumdar-Shaw

Over 60 foreign envoys visit leading pharma companies in Hyderabad

Bharat Biotech’s intranasal COVID-19 vaccine to enter phase 1 trials next month

Bharat Biotech seeks emergency use authorisation for indigenously developed COVID-19 vaccine Covaxin

Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS

Bharat Biotech confirms volunteer was hospitalised during Covaxin vaccine trial, says illness unrelated

Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ enters phase-3 trials

Bharat Biotech planning to launch Covid-19 vaccine ‘Covaxin’ in second quarter of 2021

Bharat Biotech’s ‘COVAXIN’ gets approval for phase 3 trials in India

Bharat Biotech asked to submit complete ph 2 data of its COVID-19 vaccine before ph 3 trial

Mass production of COVID-19 vaccine to begin in India once scientists give nod: PM

Bharat Biotech starts human trial of its anti-COVID vaccine at PGI Rohtak


Latest Additions

Amit Shah says three farm laws will help farmers’ income increase manifold

Will incorporate ‘Karnataka-occupied areas’ into Maha: Uddhav

Earthquake of magnitude 4.1 strikes J&K

Coronavirus found on ice cream in Chinese city

Four-year-old girl reunites with family with auto driver’s help

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.